CroíValve

Overview

CroíValve develops a minimally invasive tricuspid heart valve device. It is intended to help patients with tricuspid regurgitation, an underdiagnosed and undertreated heart disease.

Related

• 21st.BIO A/SBuilds a precision fermentation technology platform providing strains, fermentation processes, and downstream workflows for…
• AbbelightAbbelight provides workflow solutions for biological imaging, sample preparation, and data analysis.
• Ability PharmaceuticalsAbilityPharma develops biopharmaceutical drug candidates. Its clinical pipeline targets cancer treatment, including ABTL0812 trials for…
• AbInitio BioBuilds an AI-native operating platform for drug development and manufacturing, helping teams assess developability, accelerate process…
• ACIES BIO d.o.o.Builds end-to-end solutions in microbial biotech for industrial customers needing strain development, bioprocess scale-up, downstream…
• AdialanteProvides mobile, diagnostic-grade MRI services that scan patients on site at clinics, helping practices bring MRI in-house without…
• ADmit Therapeutics S.L.ADmit Therapeutics S.L. is a frontier-technology company operating from Carretera Laurea Miro 48, Spain.
• Aenitis TechnologiesDevelops devices and consumables using patented acoustic levitation for contact-free cell handling; used by bioprocessing workflows and…
• AerogenAerogen makes nebuliser systems that deliver aerosol medications.
• Agen BiotechDevelops and supplies hyaluronic acid–based products for research, industrial and cosmetic applications, serving laboratories and companies…
• Agomab TherapeuticsAgomab develops biopharmaceutical therapies for fibro-inflammatory conditions, targeting the TGFß/ALK5 pathway and advancing candidates for…
• Aidian OyAidian develops, makes, and distributes CE-marked in vitro diagnostic tests.